Abstract:
Proteinuria is an important prognostic marker in the diagnosis and management of kidney diseases. Sulfosalicylic acid method
(SSA) is a simple, low cost, qualitative test, widely used to assess proteinuria. ,e aim of this study was to optimize SSA test as a
quantitative screening tool to assess proteinuria at lower excretory levels which would facilitate the screening and early diagnosis
of renal impairment using protein-to-creatinine ratio (PCR). ,e study was conducted in two phases. In phase I, optimum SSA
percentage to detect low-grade proteinuria was selected by comparing the performance of 3%, 6%, and 25% SSA methods in
manual spectrophotometric analysis. In phase II, clinical applicability of the optimized method was evaluated using retained urine
samples of patients with chronic kidney disease (CKD) assessed for urine protein by the pyrogallol red (PGR) method in a tertiary
care hospital in Sri Lanka. Optimized 25% SSA protein-to-creatinine ratio (PCR) was compared with PGR PCR and albumin-to creatinine ratio (ACR). Sensitivity, specificity, degree of agreement, correlation, and diagnostic accuracy were evaluated. Tur bidimetric analysis using 25% SSA was linear in the range 3–50 mg/dL giving the highest analytical sensitivity. ,e test yielded a
sensitivity of 86.5% and specificity of 96.5% and a degree of agreement of 5 mg/dL with the PGR method. Optimal cut-off for 25%
SSA PCR in receiver operating characteristic analysis was 166 mg/g. Spearman’s correlation coefficient for 25% SSA PCR versus
ACR was r � 0.823, p < 0.0001, and for 25% SSA PCR versus PGR PCR was r � 0.913, p < 0.0001. ,e 25% SSA PCR has a sensitivity
of 92% against ACR, the current prognostic marker for proteinuria in patients with CKD. ,e 25% SSA test is a simple method,
and it performs satisfactorily as a screening test with a cut-off for PCR optimized at 166 mg/g. ,e test merits further evaluation
due to its low cost.